Literature DB >> 19844078

Prenatal diagnosis of androgen insensitivity syndrome.

S Bianca1, A Cataliotti, G Bartoloni, I Torrente, B Barrano, G Boemi, M Lo Presti, L Indaco, C Barone, G Ettore.   

Abstract

Androgen insensitivity syndrome (AIS) (OMIM 300068) is an X-linked recessive genetic disorder with an XY karyotype that is caused by androgen receptor (AR) defects. We report a prenatal diagnosis case with clinical and molecular findings. The fetal phenotype was female, moreover the autopsy revealed the presence of abdominal testes confirmed by histopathological examination. The AR gene molecular analysis performed on the fetal DNA showed the presence of a c.2493C>T change in exon 4. The single nucleotide change resulted in a Q711X amino acid substitution within the AR ligand-binding domain of the protein that has never been described before in the literature. AIS is an important consideration in pregnancies that show sex discordance in ultrasonography and karyotype results with the opportunity to perform molecular analysis of the AR gene in order to confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19844078     DOI: 10.1159/000251712

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  3 in total

Review 1.  Clinical spectrum of female genital malformations in prenatal diagnosis.

Authors:  Michael R Mallmann; Ulrich Gembruch
Journal:  Arch Gynecol Obstet       Date:  2022-02-27       Impact factor: 2.344

2.  Surface rendering of external genitalia of a fetus at the 32nd week of gestation affected by partial androgen insensitivity syndrome.

Authors:  Vincenzo Mazza; Emma Bertucci; Silvia Latella; Carlotta Cani; Pierluca Ceccarelli; Lorenzo Iughetti; Fulvia Baldinotti; Antonio Percesepe
Journal:  Case Rep Obstet Gynecol       Date:  2013-08-19

Review 3.  The evolving role of genetic tests in reproductive medicine.

Authors:  Federica Cariati; Valeria D'Argenio; Rossella Tomaiuolo
Journal:  J Transl Med       Date:  2019-08-14       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.